Hutchinson Gilford Progeria Syndrome (HGPS) Therapeutics Market:...

добавлена новая статья Wellness

2026-07-30 12:15:41 -

Hutchinson Gilford Progeria Syndrome (HGPS) Therapeutics Market: Niche Yet Rapidly Evolving Landscape Driven by Urgent Need for Targeted Treatments, Rare Disease Regulatory Support, and Advancing Therapeutic Pipeline for Ultra-Rare Genetic Disorder

The Hutchinson Gilford Progeria Syndrome (HGPS) Therapeutics Market is characterized by its niche yet rapidly evolving landscape, driven by the urgent need for targeted treatments for this ultra-rare genetic disorder. The market was valued at approximately USD 108 million in 2024 and is anticipated to reach USD 213.6 million by 2032, growing at a CAGR of 8.89% during the forecast period. This...

0 Комментарии 0 Поделились 453 Просмотры 0 предпросмотр